Home > Insider Trading > Filing (0001415889-21-001243)

Filing Details

Accession Number:: 0001415889-21-001243
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-03 16:10:35
Reporting Period:: 2021-03-01

Accepted Time:: 2021-03-03 16:10:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1733294	Generation Bio Co.	GBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1732701	Geoff Mcdonough	C/O Generation Bio Co., 301 Binney St Cambridge MA 02142	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-03-01	1,390	$36.35	1,202,690	No	4	S	Direct
Common Stock	Disposition	2021-03-01	4,321	$37.44	1,198,369	No	4	S	Direct
Common Stock	Disposition	2021-03-01	4,289	$38.12	1,194,080	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	226,462	Indirect	By 2018 Trust
Common Stock	275,000	Indirect	By 2020 Trust

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.82 to $36.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.86 to $37.82, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.87 to $38.73, inclusive.
The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the Trust. The reporting person is the settlor of the Trust, Allison L. McDonough and David S. Grayzel are trustees for the Trust and the Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the Trust.
The securities are directly held by the McDonough Family 2020 Irrevocable Trust (the "2020 Trust"). The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust.